Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duavee in Women With Menopausal Symptoms at Increased Risk for Breast Cancer
NCT04379024Phase 1Terminated
- Start
- Jun 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bazedoxifene in hot flashes and breast cancer (2 arms). Primary endpoint: Number of potential participants who consent to enrollment. Started Jun 2020; status: terminated.
02
Drugs
bazedoxifene
03
Conditions
hot flashesbreast cancer
Beyond the preview
Go deeper on NCT04379024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04379024.